541 results match your criteria: "Center for Infection and Immunity Amsterdam[Affiliation]"
Viruses
February 2016
Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
The list of recently discovered gastrointestinal viruses is expanding rapidly. Whether these agents are actually involved in a disease such as diarrhea is the essential question, yet difficult to answer. In this review a summary of all viruses found in diarrhea is presented, together with the current knowledge about their connection to disease.
View Article and Find Full Text PDFPLoS One
July 2016
Laboratory of Biomedical Science, Feinstein Institute for Medical Research, North Shore Long Island University Hospital, Manhassat, New York, United States of America.
Klebsiella species is the second most commonly isolated gram-negative organism in sepsis and a frequent causative pathogen in pneumonia. The receptor for advanced glycation end products (RAGE) is expressed on different cell types and plays a key role in diverse inflammatory responses. We here aimed to investigate the role of RAGE in the host response to Klebsiella (K.
View Article and Find Full Text PDFBMC Infect Dis
January 2016
Amsterdam Institute of Global Health and Development (AIGHD), Academic Medical Center (AMC), Amsterdam, The Netherlands.
Background: Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to increase HIV testing rate and HIV case finding among outpatients in Rwandan health facilities (HF).
Methods: PITC was introduced in six HFs in 2009-2010.
Autophagy
October 2016
kb Emory University, School of Medicine, Department of Microbiology and Immunology , Atlanta , GA , USA.
Mol Ther
March 2016
Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Several recent studies demonstrated that the clustered regularly interspaced short palindromic repeats (CRISPR)-associated endonuclease Cas9 can be used for guide RNA (gRNA)-directed, sequence-specific cleavage of HIV proviral DNA in infected cells. We here demonstrate profound inhibition of HIV-1 replication by harnessing T cells with Cas9 and antiviral gRNAs. However, the virus rapidly and consistently escaped from this inhibition.
View Article and Find Full Text PDFIntensive Care Med
March 2016
Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Room G2-130, 1105 AZ, Amsterdam, The Netherlands.
Purpose: Sepsis is a major health burden worldwide. Preclinical investigations in animals and retrospective studies in patients have suggested that inhibition of platelets may improve the outcome of sepsis. In this study we investigated whether chronic antiplatelet therapy impacts on the presentation and outcome of sepsis, and the host response.
View Article and Find Full Text PDFAIDS
April 2016
aDepartment of Global Health, Academic Medical Center and Amsterdam Institute for Global Health and Development bDepartment of Neurology cDepartment of Radiology dDivision of Infectious Diseases, Department of Internal Medicine, Center for Infection and Immunity Amsterdam (CINIMA) eDepartment of Experimental Immunology fDepartment of Medical Psychology, Academic Medical Center gDepartment of Psychology, University of Amsterdam hPublic Health Service Amsterdam, Infectious Diseases Research iDepartment of Neurology, Onze Lieve Vrouwe Gasthuis jDutch HIV Monitoring Foundation, Amsterdam, The Netherlands. *See "Acknowledgements" section for details concerning the AGEhIV Study Group.
Objective: The spectrum of risk factors for HIV-associated cognitive impairment is likely very broad and includes not only HIV/antiretroviral therapy-specific factors but also other comorbid conditions. The purpose of this current study was to explore possible determinants for decreased cognitive performance.
Design And Methods: Neuropsychological assessment was performed on 103 HIV-1-infected men with suppressed viraemia on combination antiretroviral therapy for at least 12 months and 74 HIV-uninfected highly similar male controls, all aged at least 45 years.
Int Arch Occup Environ Health
May 2016
Cluster Infectious Diseases, Department of Research, Public Health Service, Amsterdam, Nieuwe Achtergracht 100, 1018 WT, Amsterdam, The Netherlands.
Purpose: To explore whether the prevalence and determinants of insufficient work ability (WA) of older HIV-positive workers differ from a comparable group of HIV-negative workers.
Methods: Cross-sectional data from 359 HIV-negative and 264 HIV-positive middle-aged individuals (45-65 years) participating in paid labor, collected within the AGEhIV Cohort Study between October 2010-September 2012, were selected. Data were collected by self-administered questionnaires and physical examination.
AIDS
January 2016
aDepartment of Radiology, Academic Medical CenterbDepartment of Global Health, Academic Medical Center, and Amsterdam Institute for Global Health and Development (AIGHD)cDepartment of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam (CINIMA)dDepartment of Neurology, Academic Medical Center, Amsterdam, the NetherlandseThe Computational, Cognitive, and Clinical Neuroimaging Laboratory, Department of Medicine, Imperial College London, London, United KingdomfQuantitative Imaging Group, Delft University of Technology, DelftgCluster Infectious Diseases Research, Public Health Service of AmsterdamhDepartment of Neurology, OnzeLieveVrouweGasthuis (OLVG Hospital)iHIV Monitoring Foundation, Amsterdam, The Netherlands.
Objective: Cognitive impairment is highly prevalent in HIV-1-infected (HIV+) patients, despite adequate suppression of viral replication by combination antiretroviral therapy (cART). Cerebral white matter structure alterations are often associated with cognitive impairment and have commonly been reported in the natural course of HIV infection. However, the existence of these alterations in adequately treated HIV+ patients remains unknown, as well as its possible association with cognitive impairment.
View Article and Find Full Text PDFPLoS One
July 2016
Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, the Netherlands.
The Gram-negative bacterium Burkholderia pseudomallei causes melioidosis and is a CDC category B bioterrorism agent. Toll-like receptor (TLR)-2 impairs host defense during pulmonary B.pseudomallei infection while TLR4 only has limited impact.
View Article and Find Full Text PDFAIDS
January 2016
aDepartment of Global Health, Academic Medical Center and Amsterdam Institute for Global Health and Development bDivision of Infectious Diseases and Center for Infection and Immunity Amsterdam (CINIMA) cDepartment of Neurology, Academic Medical Center dDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands eDivision of Medicine, McGill University Hospital Center, Montreal, Canada fHIV Monitoring Foundation, Amsterdam, The Netherlands.
Background: Frailty is an age-related syndrome of decreased physiological reserve and resistance to stressors, associated with increased morbidity and mortality in the general elderly population. An increased prevalence of frailty has been reported amongst HIV-infected individuals.
Methods: Fried frailty phenotype was systematically assessed in predominantly virologically suppressed HIV type 1 (HIV-1)-infected and otherwise comparable HIV-uninfected participants aged at least 45 at enrollment into the AGEhIV Cohort Study.
Retrovirology
December 2015
Viral Pathogens and Biosafety Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, P2-P3 Laboratories, DIBIT, Via Olgettina n.58, 20132, Milan, Italy.
Background: Intracellular defense proteins, also referred to as restriction factors, are capable of interfering with different steps of the viral life cycle. Among these, we have shown that Tripartite motif 22 (TRIM22) suppresses basal as well as phorbol ester-induced HIV-1 long terminal repeat (LTR)-mediated transcription, independently of its E3 ubiquitin ligase activity, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) binding to the U3 region and Tat interaction with the TAR region of the HIV-1 LTR. As basal HIV-1 transcription is driven by the transcription factor specificity protein 1 (Sp1), we have investigated whether TRIM22 could interfere with Sp1-driven transcriptional activation of the HIV-1 LTR.
View Article and Find Full Text PDFJ Control Release
January 2016
AO Research Institute Davos, AO Foundation, Clavadelerstrasse 8 Davos Platz, CH7270 Davos, Switzerland.
The scarcity of current antibiotic-based strategies to prevent biomaterial-associated infections (BAI) and their risk of resistance development prompted us to develop a novel antimicrobial implant-coating to prevent Staphylococcus aureus-induced BAI. We incorporated the antimicrobial peptide OP-145 into a Polymer-Lipid Encapsulation MatriX (PLEX)-coating to obtain high peptide levels for prolonged periods at the implant-tissue interphase. We first confirmed that OP-145 was highly effective in killing S.
View Article and Find Full Text PDFVirology
January 2016
Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address:
Conditionally replicating HIV-1 variants that can be switched on and off at will are attractive tools for HIV research. We previously developed a genetically modified HIV-1 variant that replicates exclusively when doxycycline (dox) is administered. The nef gene in this HIV-rtTA variant was replaced with the gene encoding the dox-dependent rtTA transcriptional activator.
View Article and Find Full Text PDFJ Clin Virol
December 2015
Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address:
Background And Objective: The urgency of ebolavirus drug development is obvious in light of the current local epidemic in Western Africa with high morbidity and a risk of wider spread. We present an in silico study as a first step to identify inhibitors of ebolavirus polymerase activity based on approved antiviral nucleotide analogues.
Study Design: Since a structure model of the ebolavirus polymerase is lacking, we performed combined homology and ab initio modeling and report a similarity to known polymerases of human enterovirus, bovine diarrhea virus and foot-and-mouth disease virus.
Pathog Dis
February 2016
Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, 1081 HV, the Netherlands.
Chlamydia trachomatis infections demonstrate remarkable differences in clinical course that are approximately 40% based on host genetic variation. Here, we study the single nucleotide polymorphisms (SNPs) and their haplotypes in TLR2, TLR4 and TLR9 (TLR2 +2477G>A; TLR2 -16934T>A; TLR4+896A>G; TLR9 -1237T>C and TLR9 +2848G>A) in relation to the susceptibility to, and severity of C. trachomatis infections.
View Article and Find Full Text PDFAIDS
December 2015
Centre for Geographic Medicine Research-Coast, Kenya Medical Research Institute, Kilifi, Kenya.
Objective: To describe changes in sexual risk behavior among Kenyan MSM who received regular risk reduction counseling (RRC).
Design: Data were derived from two cohorts of HIV-1-negative and HIV-1-positive MSM in Kenya. Behavioral data were collected at enrollment and at monthly or quarterly scheduled follow-up visits.
Neurology
January 2016
From the Department of Pediatric Hematology, Immunology and Infectious Diseases (S.C., H.J.S., T.W.K., D.P.), Emma Children's Hospital AMC, Amsterdam; the Department of Radiology (M.W.A.C., H.-J.M., C.B.L.M.M.), the Department of Global Health and Amsterdam Institute of Global Health and Development (P.R.), and the Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam (CINIMA) (P.R.), Academic Medical Centre, University of Amsterdam; and HIV Monitoring Foundation (P.R.), Amsterdam, the Netherlands.
Objective: The current study aims to evaluate the neurologic state of perinatally HIV-infected children on combination antiretroviral therapy and to attain a better insight into the pathogenesis of their persistent neurologic and cognitive deficits.
Methods: We included perinatally HIV-infected children between 8 and 18 years and healthy controls matched for age, sex, ethnicity, and socioeconomic status. All participants underwent a 3.
Eur J Clin Pharmacol
February 2016
Center for Infection and Immunity Amsterdam (CINIMA), Division of Infectious Diseases, Department of Internal Medicine, Academic Medical Center, Room F4-217, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
AIDS
November 2015
aDepartment of Zoology, The Institute for Emerging Infections, The Oxford Martin School, Oxford University bNuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom cMedical Research Council Laboratories (UK), Fajara, The Gambia dDepartment of Infection and Immunity, The University of Sheffield Medical School, Sheffield, United Kingdom eErasmus Medical Centre, Medical Microbiology and Infectious Diseases, Rotterdam fHealth Service of Amsterdam (GGD) and Academic Medical Center gDepartment of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Meibergdreef, Amsterdam, The Netherlands hProjecto de Saúde de Bandim, Apartado 861, Bissau Codex, Guinea-Bissau iFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Objective: This article predicts the future epidemiology of HIV-2 in Caió, a rural region of Guinea Bissau; and investigates whether HIV-2, which has halved in prevalence between 1990 and 2007 and is now almost absent in young adults in Caió, can persist as an infection of the elderly.
Design: A mathematical model of the spread of HIV-2 was tailored to the epidemic in Caió, a village in Guinea-Bissau.
Methods: An age-stratified difference equation model of HIV-2 transmission was fitted to age-stratified HIV-2 incidence and prevalence data from surveys conducted in Caió in 1990, 1997 and 2007.
Genom Data
June 2015
Clermont Université, Université Blaise Pascal-Université d'Auvergne-CNRS, UMR 6023 Laboratoire Microorganismes: Génome et Environnement, Clermont-Ferrand, France.
The intestinal protistan parasite Blastocystis is characterized by an extensive genetic variability with 17 subtypes (ST1-ST17) described to date. Only the whole genome of a human ST7 isolate was previously sequenced. Here we report the draft genome sequence of Blastocystis ST4-WR1 isolated from a laboratory rodent at Singapore.
View Article and Find Full Text PDFJ Infect
January 2016
Center for Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA. Electronic address:
Objective: The objective of this analysis was to assess human papillomavirus (HPV) infection persistence and incidence 7-months post-enrollment by HPV vaccine study arm (vaccine or placebo).
Methods: HIV-negative, sexually active women aged 16-24 years in the Western Cape, South Africa, were enrolled in the EVRI Trial and were randomized to receive 4-valent HPV vaccine or placebo. Cervical specimens were collected at enrollment and at the 7-month visit and were genotyped for HPV.
AIDS
January 2016
aDepartment of Infectious Diseases, Public Health Service AmsterdambDepartment of Internal Medicine, Center for Infection and Immunity Amsterdam (CINIMA)cDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, AmsterdamdCentre for Infectious Disease Control, National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM), BilthoveneJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, UtrechtfDepartment of Pathology, Vrije Universiteit-University Medical Center (VUmc)gDepartment of Dermatology, Academic Medical CenterhDepartment of Internal Medicine, Jan van Goyen Medical Center, Amsterdam, The Netherlands.*Present address: DC Klinieken Oud Zuid, Amsterdam, The Netherlands.
Objectives: A large portion of anogenital cancers is caused by high-risk human papillomavirus (hrHPV) infections, which are especially common in HIV-infected men. We aimed to compare the incidence and clearance of anal and penile hrHPV infection between HIV-infected and HIV-negative MSM.
Design: Analyses of longitudinal data from a prospective cohort study.
PLoS One
July 2016
Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
High levels of adherence to antiretroviral therapy (ART) are necessary for achieving and maintaining optimal virological suppression, as suboptimal adherence leads to therapy failure and disease progression. It is well known that adherence to ART predicts therapy response, but it is unclear whether clinical outcomes of ART predict adherence. To examine the predictive power of current CD4+ T cell count for adherence of HIV-infected individuals to ART, we performed a cross-sectional analysis of 133 Dutch HIV patients with electronically measured adherence.
View Article and Find Full Text PDFIntensive Care Med
March 2016
Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Purpose: Cytomegalovirus (CMV) reactivation occurs frequently in patients with the acute respiratory distress syndrome (ARDS) and has been associated with increased mortality. However, it remains unknown whether this association represents an independent risk for poor outcome. We aimed to estimate the attributable effect of CMV reactivation on mortality in immunocompetent ARDS patients.
View Article and Find Full Text PDF